CRH Medical Corporation (CRH) specializes in the distribution of medical products directly to physicians, particularly those in the gastroenterologist community. The Company's lead product, the CRH O'Regan System, is a single use, disposable, hemorrhoid treatment that is used in treating hemorrhoid grades I-IV. In addition to the product, CRH delivers clinical, marketing and operational support directly to its partner physicians. CRH utilizes its Web-based platform to connect doctors with patients, as well as educating its install base of physicians.
Industry, Sector and Symbol
Stock Exchange CVE
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolCVE:CRM
CUSIPN/A
Phone+1-604-6331440
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares722,300,000
Market CapC$31.20 million
CRH Medical (CVE:CRM) Frequently Asked Questions
What is CRH Medical's stock symbol?
CRH Medical trades on the Canadian Venture Exchange (CVE) under the ticker symbol "CRM."
Who are CRH Medical's key executives?
CRH Medical's management team includes the folowing people:
- Anthony F. Holler M.D., Independent Chairman of the Board (Age 63)
- Edward J. Wright, Chief Executive Officer, Director
- Richard K. Bear, Chief Financial Officer (Age 48)
- Jay Kreger, President of CRH Anesthesia Management
- David Johnson, Independent Director
- Bergein F. Overholt M.D., Independent Director
- Todd R. Patrick, Independent Director (Age 48)
- Ian A. Webb, Independent Director (Age 61)
Has CRH Medical been receiving favorable news coverage?
News coverage about CRM stock has trended somewhat positive this week, Accern Sentiment reports. Accern ranks the sentiment of press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. CRH Medical earned a news and rumor sentiment score of 0.07 on Accern's scale. They also assigned news stories about the company an impact score of 47.03 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term. View Recent Headlines for CRH Medical.
How do I buy shares of CRH Medical?
Shares of CRM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is CRH Medical's stock price today?
One share of CRM stock can currently be purchased for approximately C$119.26.
How big of a company is CRH Medical?
CRH Medical has a market capitalization of C$31.20 million.
How can I contact CRH Medical?
CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.
MarketBeat Community Rating for CRH Medical (CVE CRM)
MarketBeat's community ratings are surveys of what our community members think about CRH Medical and other stocks. Vote "Outperform" if you believe CRM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRM will underperform the S&P 500 over the long term. You may vote once every thirty days.
